Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0000950144-07-006748
Filing Date
2007-07-23
Accepted
2007-07-23 14:46:27
Documents
8

Document Format Files

Seq Description Document Type Size
1 CUMBERLAND PHARMACEUTICALS INC. g06286a4sv1za.htm S-1/A 2064840
2 EX-1.1 FORM OF UNDERWRITING AGREEMENT g06286a4exv1w1.htm EX-1.1 162463
3 EX-5.1 OPINION OF ADAMS AND REESE LLP g06286a4exv5w1.htm EX-5.1 4204
4 EX-10.8 STRATEGIC ALLIANCE AGREEMENT g06286a4exv10w8.htm EX-10.8 170190
5 EX-10.16.3 SECOND AMENDMENT TO SECOND AMENDED AND RESTATED LOAN AGREEMENT g06286a4exv10w16w3.htm EX-10.16.3 29983
6 EX-23.1 CONSENT OF KPMG LLC g06286a4exv23w1.htm EX-23.1 2804
7 GRAPHIC g06286a4g0628602.gif GRAPHIC 3768
8 GRAPHIC g06286a4g0628610.gif GRAPHIC 337
  Complete submission text file 0000950144-07-006748.txt   2441648
Mailing Address
Business Address 209 TENTH AVENUE SOUTH SUITE 332 NASHVILLE, TN 37203
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: S-1/A | Act: 33 | File No.: 333-142535 | Film No.: 07993563
SIC: 2834 Pharmaceutical Preparations